Literature DB >> 1137831

Effect of trimethoprim-sulfamethoxazole on blood insulin and glucose concentrations of diabetics.

M Mihic, L S Mautner, J Z Feness, K Grant.   

Abstract

Trimethoprim-sulfamethoxazole (TMP-SMX) caused no significant changes in the blood glucose or insulin concentrations of diabetic subjects treated by dietary measures alone or by insulin and diet. In only one of eight subjects receiving oral hypoglycemic agents for the control of diabetes did a significant immediate increase in immunoreactive insulin follow administration of TMP-SMX. In the same patient hypoglycemic symptoms were present after the agent had been taken for 14 days.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1137831      PMCID: PMC1956436     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  6 in total

1.  SULPHAPHENAZOLE-INDUCED HYPOGLYCAEMIC ATTACKS IN TOLBUTAMIDE-TREATED DIABETICS.

Authors:  L K CHRISTENSEN; J M HANSEN; M KRISTENSEN
Journal:  Lancet       Date:  1963-12-21       Impact factor: 79.321

2.  Protein interactions of sulfonylurea compounds.

Authors:  H WISHINSKY; E J GLASSER; S PERKAL
Journal:  Diabetes       Date:  1962       Impact factor: 9.461

3.  [The binding of long-acting sulfonamides on serum proteins. 2].

Authors:  W SCHOLTAN
Journal:  Arzneimittelforschung       Date:  1961-08

4.  [Potentiation of tolbutamide by phenylbutazone].

Authors:  R GULBRANDSEN
Journal:  Tidsskr Nor Laegeforen       Date:  1959-10-01

5.  Changes induced by insulin and tolbutamide in the glucose output of the liver.

Authors:  P SCHAMBYE; F TARDING
Journal:  Ann N Y Acad Sci       Date:  1959-03-30       Impact factor: 5.691

6.  Clinical and experimental studies of insulin secretion following tolbutamide and metahexamide administration.

Authors:  E F PFEIFFER; M PFEIFFER; H DITSCHUNEIT; C S AHN
Journal:  Ann N Y Acad Sci       Date:  1959-09-25       Impact factor: 5.691

  6 in total
  5 in total

1.  Inhibition of Porcine Pancreatic Amylase Activity by Sulfamethoxazole: Structural and Functional Aspect.

Authors:  Sujan Maity; Koel Mukherjee; Amrita Banerjee; Suman Mukherjee; Dipak Dasgupta; Suvroma Gupta
Journal:  Protein J       Date:  2016-06       Impact factor: 2.371

Review 2.  Drug-induced hypoglycaemia: an update.

Authors:  Chaker Ben Salem; Neila Fathallah; Houssem Hmouda; Kamel Bouraoui
Journal:  Drug Saf       Date:  2011-01-01       Impact factor: 5.606

3.  Clinical pharmacokinetics of co-trimoxazole (trimethoprim-sulphamethoxazole).

Authors:  R B Patel; P G Welling
Journal:  Clin Pharmacokinet       Date:  1980 Sep-Oct       Impact factor: 6.447

4.  Cotrimoxazole as an inhibitor of oxidative drug metabolism: effects of trimethoprim and sulphamethoxazole separately and combined on tolbutamide disposition.

Authors:  L M Wing; J O Miners
Journal:  Br J Clin Pharmacol       Date:  1985-11       Impact factor: 4.335

Review 5.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.